Healthy and COPD Participants to Evaluate the Efficacy and Safety of Inhaled TV46017

- Chronic Obstructive Pulmonary Disease (COPD)
- Terminated

Study Title: Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017

Teva Identifier: TV46017-COPD-10046

ClinicalTrials.gov Identifier: NCT02315131

Study Status: Terminated

Trial Condition(s): Chronic Obstructive Pulmonary Disease (COPD)

Interventions: Drug: TV46017 | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 20 Years to 75 Years

Trial Duration: 03/01/2015 - 08/01/2015

Phase: Phase 1

Study Type

Interventional